Bialetti Industrie — Board/Management Information 2020

Dec 30, 2020

Carlo Francesco Frau has more than thirty years working experience in different jobs (private equity, company management, company restructurings, management consulting, M&A, audit), in different countries (Italy, Germany, France, USA, UK and Switzerland) and in different sectors (pharma ingredients, food, branded products)

In 1978 he graduated cum laude at Università Luigi Bocconi after a year in France at ESSEC and in 1981 he passed the Certified Public Accountant certificate in the USA

He is fluent in Italian, English, French and German and has notions in Spanish

Since 2010 with the DeAgostini group in Private Equity, Real Estate and Management of portfolio companies:

• Since 2015 Managing Director of two Private Equity funds with DeA Capital Alternative Funds SGR: Investitori Associati IV (AuM € 700mln) and IDeA Opportunity I (AuM € 220mln)
• In 2015-16 CEO of Innovation RE, a real estate services company Project, Property and Facility Management
• In 2010-15 Head of Strategy and Development at the quoted investment company DeA Capital, managing portfolio companies (Générale de Santé, Migros in Turkey, DeA Capital Real Estate SGR)

Prior to that, CEO for crisis management, turnarounds and company restructurings:

• In 2006-09 Chairman and CEO of Cuki Domopak (controlled by M&C) turnover € 400mln; company turnaround – restructured debt; repositioned brand and industrial base; improved results
• In 2004-05 Head of international (Australia, Canada, Colombia, Cuba, Ecuador, Nicaragua, Paraguay, Portugal, Romania, Russia, South Africa, Spain, Venezuela, Boschi Luigi - Doubled profitability) and non-core activities (Brazil, Germany, Mexico, Emmegi Agrumi, Farmland Dairies and US Dairy in Chapter 11, Gelaterie, Italcheese, Strini Costruzioni, Mister Day and Grisbì, Mother's Biscuits and Archway, Parmatour – Orderly exit for all companies) at Parmalat in Amministrazione Straordinaria – turnover in excess of € 2,6bln; crises management, turnarounds and restructurings
• In 2000-03 Chairman and CEO of Antibioticos (controlled by Montedison) turnover € 300mln; company turnaround – brought back to profitability in two years

Earlier, some years spent in Strategy, Management Consulting, M&A and Audit:

• In 1999-2000 Head of Strategy and Development at Montedison; managing portfolio companies (Antibioticos; Ausimont, Syremont; Calcemento, Heracles; Edison Energy, Edison Gas, Edisontel; Eridania Béghin-Say, Céreol, Cérestar, Provimi; Intermarine; Tecnimont)
• In 1994-98 Management Consulting with CapGemini/E&Y in Milan and Paris
• In 1981-94 Investment Banking (Structured Finance, M&A and Private Equity) with Banque Sudameris, Citibank and JPMorgan/Chase in Paris, London, Milan and Geneva
• In 1978-81 Auditor with KPMG in Frankfurt, New York and Paris.